Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.

doi:10.4238/2012.September.26.4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.

Genetics and molecular research : GMR - 26 Sept 2012

Zhong D Y, Chu H Y, Wang M L, Ma L, Shi D N, Zhang Z D

Abstract excerpt

The functional polymorphism Ser326Cys (rs1052133) in the human 8-oxoguanine DNA glycosylase (hOGG1) gene has been implicated in bladder cancer risk. However, reports of this association between the Ser326Cys polymorphism and bladder cancer risk are conflicting. In order to help clarify this relationship, we made a meta-analysis of seven case-control studies, summing 2521 cases and 2408 controls. We used odds...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Glycosylases

Share to Genetic Association Studies

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Publication Bias

Share to Risk Factors

Share to Urinary Bladder Neoplasms

Source

Open in PubMed

Identifiers

PMID: 23079842
DOI: 10.4238/2012.September.26.4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meta-analysis demonstrates lack of association of the hOGG1 Ser326Cys polymorphism with bladder cancer risk.PMID 23079842Read ↗

Lack of association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer: a meta-analysis.Semantic proximity Read ↗

hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.Semantic proximity Read ↗

Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies.Semantic proximity Read ↗

The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis.Semantic proximity Read ↗

Association of OGG1 Ser326Cys polymorphism with colorectal cancer risk: a meta-analysis.Semantic proximity Read ↗

Association of hOGG1 Ser326Cys polymorphism with gastric cancer risk: a meta-analysis.Semantic proximity Read ↗

Meta-analysis of the association between hOGG1 Ser326Cys polymorphism and risk of colorectal cancer based on case--control studies.Semantic proximity Read ↗

The hOGG1 Ser326Cys polymorphism contributes to digestive system cancer susceptibility: evidence from 48 case-control studies.Semantic proximity Read ↗

An association between hOGG1 Ser326Cys polymorphism and the risk of bladder cancer in non-smokers: a meta-analysis.Semantic proximity Read ↗

Lack of association between the hOGG1 gene Ser326Cys polymorphism and gastric cancer risk: evidence from a case-control study and a meta-analysis.Semantic proximity Read ↗

The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.Semantic proximity Read ↗

The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: evidence from 83 case-control studies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.